Portable Epilepsy Monitoring Market Size is predicted to show a 7.15% CAGR during the forecast period for 2023-2031.
Epilepsy monitoring devices play a crucial role in the individualized and data-driven approach to managing epilepsy, leading to more successful treatment options and enhanced quality of life for individuals with epilepsy.
The global portable epilepsy monitoring market's growth is primarily driven by the rising worldwide incidence of epilepsy, underscoring the urgent need for effective and efficient monitoring solutions. Significant advancements and innovations in portable epilepsy monitoring technologies have played a vital role in supporting market expansion. These noteworthy technological breakthroughs have paved the way for the development of highly advanced and user-friendly portable monitoring devices that cater to the evolving needs of both patients and healthcare professionals.
Furthermore, in prosperous nations, market growth is being driven by a combination of factors, including the elevated risk associated with widespread infectious diseases such as malaria and neurocysticercosis, the increasing occurrence of issues like traffic congestion and birth-related concussions, variations in healthcare technology, and the availability of preventive health programs and treatments. The market is thriving due to an upswing in research and development initiatives and the presence of a robust healthcare infrastructure in the area. With a notable prevalence of epilepsy and access to cutting-edge medical technologies, the market is well-positioned to take the lead in its expansion. Additionally, the growing emphasis on enhancing the region's healthcare infrastructure and the increasing awareness of the benefits of monitoring devices are both contributing to the market's upward trajectory.
Competitive Landscape
Some Major Key Players In The Portable Epilepsy Monitoring Market:
- Silicon Lab,
- Epilert,
- Murata Vios,
- Seer Medical,
- Telecare24 Ltd (Epilepsy Alarms UK),
- Divoti,
- Epi USA,
- SAMi,
- Breathe-zy,
- Bay Alarm Medical,
- Natus Medical, Inc. (US)
- Compumedics Limited (Australia)
- Empatica, Inc. (US)
- The Magstim Co. Ltd. (UK)
- Nihon Kohden Corporation (Japan)
- Medtronic Plc (Ireland)
- Masimo Corporation (US)
- Boston Scientific Corporation (US)
- Drägerwerk AG & Co. KGaA (Germany)
- mjn Neuroserveis S.L. (Spain)
- Abbott Laboratories, Inc. (US)
- LivAssured B.V. (Netherlands)
- BioSerenity (France)
- Aleva Neurotherapeutics (Switzerland)
- Medpage, Ltd. (UK)
- Neurosoft (Russia)
- Advanced Brain Monitoring (US)
- Lifelines Neuro Company, LLC (US)
- Mitsar Co., Ltd. (Russia)
- Rimed (US)
- Emotiv (US)
- CGX (A Cognionics Company) (US)
- Mindray Medical International Ltd. (China)
- Cadwell Industries, Inc. (US)
- NeuroWave Systems, Inc. (US)
- MC10, Inc. (US).
- Others
Market Segmentation:
The portable epilepsy monitoring market is segmented on the basis of product type and end-user. By Product Type, the market is segmented into Device Type and services. The Device type includes Chest Sensor, Watch Sensor, Monitors, Cameras, Mattresses and Pillows, and Others. The end-user segment comprises Hospitals, Ambulatory Surgery Centres & Clinics, Neurology Centres, and Home Care Settings.
Based On The Product Type, The Devices Category Is Accounted As A Major Contributor To The Portable Epilepsy Monitoring Market.
Throughout the period of forecast, the devices segment is anticipated to be the greatest. This is due to the fact that the data acquired by the portable devices assist in the treatment of the patient's seizures and aid in the daily monitoring of the patient's condition between consultations.
The ambulatory Surgical Centre's Segment Witnessed Growth At A Rapid Rate.
The ambulatory surgical centre category is projected to develop at a tremendous rate in the global portable epilepsy monitoring market. The significance of this dominance lies in the fact that when surgeries are performed within an ASC setup, they tend to be notably shorter in duration, patients tend to experience much faster recovery times, the infection rate is typically only half of that seen in hospitals, and the costs associated with outpatient surgery are often lower due to the absence of hospital room charges and associated fees.
In The Region, The North American Portable Epilepsy Monitoring Market Holds A Significant Revenue Share.
The North American portable epilepsy monitoring market is expected to register the highest market share. The market for portable epilepsy monitoring devices and applications has seen increased competition with various companies and startups offering innovative solutions. This competition can lead to more choices for patients. In addition, the Asia Pacific regional market is projected to grow at a tremendous rate in the global portable epilepsy monitoring market. The approval of portable epilepsy monitoring devices by regulatory authorities in different Asian countries is crucial. These devices must meet safety and efficacy standards to gain acceptance in the market. Some Asian countries have a significant population with epilepsy. As healthcare infrastructure improves and access to care expands, there is a greater need for innovative solutions like portable monitoring devices to enhance the quality of care for epilepsy patients.
Recent Developments:
- In Jan 2021, Medtronic introduced the Medtronic Brain Sensor, a minimally invasive implantable device to monitor brain activity in individuals with epilepsy. This innovative device is placed under the scalp and serves the purpose of identifying the origin of seizures in patients experiencing drug-resistant epilepsy.
Portable Epilepsy Monitoring Market Report Scope
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 7.15% from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
|
Competitive Landscape |
Epi USA, Empatica Inc., Medpage Ltd, Hipass Design LLC, American Medical ID, Sleep-Safe, Inspyre, Neurava, Bioserenity, MC10, Brain Sentinel, SeizAlarm, Smart Monitor, Natus Medical, Inc. (US), Compumedics Limited (Australia), Empatica, Inc. (US), The Magstim Co. Ltd. (UK), Nihon Kohden Corporation (Japan), Medtronic Plc (Ireland), Masimo Corporation (US), Boston Scientific Corporation (US), Drägerwerk AG & Co. KGaA (Germany), mjn Neuroserveis S.L. (Spain), Abbott Laboratories, Inc. (US), LivAssured B.V. (Netherlands), BioSerenity (France), Aleva Neurotherapeutics (Switzerland), Medpage, Ltd. (UK), Neurosoft (Russia), Advanced Brain Monitoring (US), Lifelines Neuro Company, LLC (US), Mitsar Co., Ltd. (Russia), Rimed (US), Emotiv (US), CGX (A Cognionics Company) (US), Mindray Medical International Ltd. (China), Cadwell Industries, Inc. (US), NeuroWave Systems, Inc. (US), and MC10, Inc. (US) and others. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
